Saitama, Japan

Asao Tanioka


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Asao Tanioka

Introduction

Asao Tanioka is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that act as tachykinin receptor antagonists. With a total of four patents to his name, Tanioka's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Tanioka's latest patents include innovative compounds such as fused bicyclic pyrimidine derivatives. These derivatives are designed to act as tachykinin receptor antagonists, specifically targeting the NK1 receptor. The general formula for these compounds includes benzene rings with various substituents and nitrogen-containing rings. Another significant patent involves fused bicyclic pyridine derivatives, which also serve as tachykinin receptor antagonists, showcasing Tanioka's focus on advancing pharmacological treatments.

Career Highlights

Throughout his career, Asao Tanioka has worked with Kyorin Pharmaceutical Co., Ltd., where he has contributed to the development of groundbreaking pharmaceutical products. His expertise in medicinal chemistry and drug design has been instrumental in the creation of effective therapeutic agents.

Collaborations

Tanioka has collaborated with notable colleagues such as Shigeki Seto and Makoto Ikeda. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical industry.

Conclusion

Asao Tanioka's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…